Safety Alerts & Recalls
Search all Safety Alerts & Recalls
Oftalmi Announces Recall of the Camolyn Eye Drops Product Line
US Oftalmi is conducting a voluntary nationwide recall of all Over-the-Counter Eye Drops and Nasal Drops. Products were packaged in 15 mL plastic bottles and were distributed nationwide to food and drug distributors for retail. These products are being recalled because conditions at the manufacturing facility cannot assure the sterility of the products. Products that are non-sterile have the potential to cause eye infections, which may affect the sight. The following products and lot numbers are being recalled: Camolyn Homeopathic - Lots 049036 and 087934 Camolyn Plus, Naphazoline + Chamomile 15 mL - Lots 037691 and 097420 Camolyn Refresh 15 mL - Lots 116636 and 107610 Camolyn-A, Naphazoline + Pheniramine 15 mL - Lots 057063, 058962, 106606, and 099487 For more information, please visit: [http://www.fda.gov/Safety/Recalls/ucm207735.htm
NSAIDS (Motrin, Advil, Aleve) may reduce the ability of aspirin to prevent a second stroke.
A recently published article in the Journal of Clinical Pharmacology discusses the effects of non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Motrin, Advil), and naproxen (Aleve), on the ability of aspirin to prevent a second stroke. Specifically, the article provides information suggesting that the use of these NSAIDS may decrease the effectiveness of aspirin for preventing the formation of new clots in patients who have previously had a stroke. For more information, please visit: http://jcp.sagepub.com/cgi/content/full/48/1/117